Jinlong Jian is an accomplished inventor based in River Edge, NJ (US). He has made significant contributions to the field of lysosomal storage diseases through his innovative research and patented inventions. With a total of 2 patents, Jian's work focuses on the treatment and diagnosis of these complex conditions.

Latest Patents

Jinlong Jian's latest patents include groundbreaking inventions related to Progranulin (PGRN) fragments and derivatives. The first patent provides peptides, compositions, and methods for the treatment and alleviation of lysosomal storage diseases, including Gaucher's Disease. This invention particularly utilizes one or more PGRN derivatives or fragments, specifically fragment ND7/Pcgin. The second patent offers compositions and methods for the diagnosis and treatment of lysosomal storage diseases, including Gaucher's Disease and Tay-Sachs disease. This invention employs PGRN or active PGRN peptides, including atsttrin. Additionally, it provides animal models of lysosomal storage diseases based on PGRN mutations, including PGRN null mutants and PGRN gene knockouts.

Career Highlights

Throughout his career, Jinlong Jian has worked with prestigious institutions such as New York University and Merck Sharp & Dohme Corp. His research has significantly advanced the understanding and treatment of lysosomal storage diseases, making him a notable figure in the field.

Collaborations

Jinlong Jian has collaborated with esteemed colleagues, including Chuanju Liu and Qingyun Tian. These partnerships have further enriched his research and contributed to the development of innovative solutions for lysosomal storage diseases.

Conclusion

Jinlong Jian's contributions to the field of lysosomal storage diseases through his patents and collaborations highlight his dedication to advancing medical science. His work continues to pave the way for new treatments and improved patient outcomes.

Profile summary based on public USPTO records.